Management of Morgellons Disease With Low-Dose Trifluoperazine. Academic Article uri icon

Overview

abstract

  • This medical record review examines the novel use of low-dose trifluoperazine, a high-potency typical antipsychotic, in a cohort of patients with Morgellons disease.

publication date

  • February 1, 2018

Research

keywords

  • Antipsychotic Agents
  • Morgellons Disease
  • Trifluoperazine

Identity

PubMed Central ID

  • PMC5839272

Scopus Document Identifier

  • 85042203555

Digital Object Identifier (DOI)

  • 10.1001/jamadermatol.2017.5175

PubMed ID

  • 29322188

Additional Document Info

volume

  • 154

issue

  • 2